On September 8, 2023, the United Mitochondrial Disease Foundation co-hosted a Patient-led Listening Session with the U.S. Food & Drug Administration for Pyruvate Dehydrogenase Complex Deficiency (PDCD) with fellow patient advocacy groups MitoAction, Hope for PDCD, and The Elizabeth Watt PDCD Research Fund.
PDCD FDA Listening Session Report Now Available
Categories
Recent Posts
- Ask the Mito Doc – March 2024; Q&A
- UMDF Announces Inaugural Venture Philanthropy Investment: The Mito Fund Invests $500k in Pierrepont Therapeutics, Inc. to Help Move a Mitochondrial Disease Therapy Forward
- Powerhouse Podcast #28: Divakar Mithal, MD, PhD
- Research Update from 2023 accelerators Runner-Up Jonathan Dietz, PhD